Cincinnati, OH, United States of America

Marc Elliot Rothenberg

This inventor holds 23 USPTO granted patents and 11 published patent applications, plus 1 CIPO patent and 7 EPO patents, primarily in Eosinophilic Disorders. Top assignees: Cincinnati Children's Hospital Medical Center, University of California, Other. Active years: 2002-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Marc Elliot Rothenberg. Retrieved from https://idiyas.com/inventor/marc-elliot-rothenberg

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 23 

% Patents Active = 82.6

 

 

Average Co-Inventor Count = 2.1

ph-index = 7

Forward Citations = 194(Granted Patents)


Location History:

  • Brookline, MA (US) (2002 - 2004)
  • Cincinnati, OH (US) (2002 - 2024)

Company Filing History:


Years Active: 2002-2025

Loading Chart...
Loading Chart...
Loading Chart...
Areas of Expertise:
Eosinophilic Esophagitis
Allergic Inflammation
Diagnostic Methods
Therapeutic Target
Genetic Testing
Blood Biomarkers
Esophageal MicroRNA
Inflammatory Conditions
Eotaxin
Cadherin 26
Eosinophilic Gastritis
NTRK1 Inhibition
23 patents (USPTO):Explore Patents

Title: Unveiling the Innovative Journey of Marc Elliot Rothenberg

Introduction:

Marc Elliot Rothenberg from Cincinnati, OH, is a renowned inventor with a remarkable portfolio of 20 patents. His groundbreaking work has significantly impacted the field of allergic and inflammatory conditions, marking him as a standout figure in the realm of medical innovation.

Latest Patents:

1. Methods for treating eosinophilic esophagitis: Rothenberg's invention focuses on identifying an EoE endotype in patients and tailoring appropriate therapies accordingly. This method revolutionizes the treatment approach for patients suffering from this condition.

2. Compositions and methods for treating allergic inflammatory conditions: By introducing a pharmaceutical composition with a KLK5 inhibitor, Rothenberg's patent offers a novel approach to treating allergic inflammatory conditions affecting the squamous epithelium.

Career Highlights:

Rothenberg has left an indelible mark on the medical landscape, with his work predominantly undertaken at renowned institutions such as Children's Hospital Medical Center. His innovative mindset and unwavering dedication have propelled him to the forefront of cutting-edge medical research.

Collaborations:

Throughout his career, Rothenberg has collaborated with esteemed professionals in the field, including coworkers Ting Wen and Julie Caldwell. These collaborations have not only enriched his work but have also fostered a culture of innovation and excellence in his professional journey.

Conclusion:

Marc Elliot Rothenberg's inventive prowess and dedication to medical innovation have not only transformed the treatment landscape for allergic and inflammatory conditions but have also set a new standard for pioneering research in the field. His contributions stand as a testament to the power of innovation and ingenuity in revolutionizing healthcare practices for the better.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…